SA
BPTH

Strategic Advocates’s Bio-Path Holdings Inc BPTH Stock Holding History

Strategic Advocates’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,756
Closed -$16.3K – 182
2023
Q4 		$16.3K Hold
1,756
– – 0.01% 150
2023
Q3 		$13K Buy
+1,756
New +$24.4K 0.01% 141

Other funds holding BPTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Strategic Advocates's BPTH Position: Q1 2024 in Review

Strategic Advocates sold out of Bio-Path Holdings Inc (BPTH) in Q1 2024, closing a stake of 1,756 shares — an estimated $16.3K sold.

Strategic Advocates first reported a position in BPTH in Q3 2023 and held it in 2 quarters. The position peaked at $16.3K in Q4 2023. 10 funds tracked by Wall St. Rank hold BPTH as of Q1 2024.

  • Strategic Advocates reported no remaining Bio-Path Holdings Inc position as of Q1 2024 after selling out during the quarter.
  • Strategic Advocates sold 1,756 Bio-Path Holdings Inc shares in Q1 2024, an estimated $16.3K.
  • Strategic Advocates first reported a position in Bio-Path Holdings Inc in Q3 2023 and held it in 2 quarters.
  • Strategic Advocates's Bio-Path Holdings Inc position peaked at $16.3K in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2024.

Based on Strategic Advocates's 13F filing for Q1 2024, filed 3 Apr 2024.